{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T12:43:52Z","timestamp":1782996232936,"version":"3.54.5"},"reference-count":73,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"unspecified","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["707700"],"award-info":[{"award-number":["707700"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,6,25]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Osteopenia, defined as a bone mineral density (BMD) T-score between \u22121.0 and \u22122.5, is a precursor to osteoporosis and fragility fracture which results in substantial morbidity. Patients with gastrointestinal (GI) cancer are particularly vulnerable due to disease-specific mechanisms of bone loss and treatment-related toxicities, which compound the risk of osteoporotic fractures and adverse oncological outcomes. Despite this, the global prevalence of osteopenia and incidence of osteoporotic fracture in GI cancer populations remains poorly quantified, limiting opportunities for targeted surveillance, preventive strategies and policy development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis will estimate the global prevalence of osteopenia and global incidence of osteoporotic fracture in cohorts of adults with non-metastatic GI cancer and explore variation across treatment type, cancer site, geographical region and diagnostic modality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      This protocol follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) guidance. We will conduct a comprehensive search of MEDLINE, Embase, CINAHL, PubMed, Web of Science, Cochrane Central and ClinicalTrials.gov from 1994 to 2026. Eligible studies will include observational or interventional cohorts reporting prevalence of osteopenia, assessed using dual-energy X-ray absorptiometry (DXA) or CT scan, or incidence of fragility fracture, as determined by imaging findings, administrative codes or clinical history in cohorts of adult non-metastatic cancer populations. Five reviewers will independently and in pairs screen citations and full-text articles, extract data, and assess study quality using the Joanna Briggs Institute checklist for prevalence studies for each outcome. The primary outcome is the global pooled prevalence of osteopenia (diagnosed using DXA), calculated using a random-effect generalised linear mixed model. Secondary outcomes are the global pooled incidence rate of fragility fracture, and the pooled fragility fracture incidence rate ratio (IRR) comparing patients with GI cancer with the general population. All estimates will be presented with 95% confidence intervals. Heterogeneity will be assessed with I\n                      <jats:sup>2<\/jats:sup>\n                      , \u03c4\n                      <jats:sup>2<\/jats:sup>\n                      and prediction intervals for each outcome. Sources of heterogeneity in osteopenia prevalence will be explored through subgroup analyses by primary cancer location, treatment exposure, and geographical region. Sensitivity analyses, including an analysis of the pooled prevalence of osteopenia diagnosed using CT, and limited to studies deemed low risk of bias, will be performed. Publication bias will be evaluated using Doi plots supplemented with Luis Furuya-Kanamori indices. We will assess certainty in the evidence-base in duplicate by using the Grading of Recommendations Assessment, Development and Evaluation methodology for systematic reviews involving prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study is a secondary analysis of aggregate, de-identified data extracted from previously published studies. As such, no new data were collected from human participants, and formal ethics board approval is not required. All aggregated data and analytical code used to complete this study will be made available on request to the corresponding author. The findings from this study will be disseminated through publication in a peer-reviewed scientific journal and presentation at national and international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD420261286673.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-119507","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:42:20Z","timestamp":1782992540000},"page":"e119507","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of osteopenia and incidence of fragility fracture in adult patients with gastrointestinal cancer: protocol for a systematic review and meta-analysis"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6518-7586","authenticated-orcid":false,"given":"Sara","family":"Bocchinfuso","sequence":"first","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheharzad","family":"Mahmood","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Yan","family":"Ip","sequence":"additional","affiliation":[{"name":"Clinical Evaluative Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Barone","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Yau","sequence":"additional","affiliation":[{"name":"Clinical Evaluative Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Brand\u00e3o","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William K","family":"Silverstein","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Shariff","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Tiano","sequence":"additional","affiliation":[{"name":"MyGutFeeling, Stomach Cancer Foundation of Canada, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4038-5382","authenticated-orcid":false,"given":"Neill K J","family":"Adhikari","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie G","family":"Coburn","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"},{"name":"Department of Surgery, University of Toronto, Toronto, Ontario, Canada"},{"name":"Clinical Evaluative Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada"},{"name":"Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"2026070204403664000_16.7.e119507.1","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650090802"},{"key":"2026070204403664000_16.7.e119507.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-022-06454-3"},{"key":"2026070204403664000_16.7.e119507.3","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(24)00225-0"},{"key":"2026070204403664000_16.7.e119507.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08657-9"},{"key":"2026070204403664000_16.7.e119507.5","doi-asserted-by":"crossref","first-page":"870905","DOI":"10.3389\/fendo.2022.870905","article-title":"Global, Regional, and National Burden of Low Bone Mineral Density From 1990 to 2019: Results From the Global Burden of Disease Study 2019","volume":"13","author":"Dong","year":"2022","journal-title":"Front Endocrinol"},{"key":"2026070204403664000_16.7.e119507.6","unstructured":"World Health Organization International Agency for Research on Cancer . Global burden of gastrointestinal cancers. Available: https:\/\/gco.iarc.fr\/stories\/gastro-intestinal\/en [Accessed 14 Oct 2025]."},{"key":"2026070204403664000_16.7.e119507.7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/jso.27213","article-title":"Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases","volume":"127","author":"Chen","year":"2023","journal-title":"J Surg Oncol"},{"key":"2026070204403664000_16.7.e119507.8","doi-asserted-by":"publisher","DOI":"10.3322\/caac.70011"},{"key":"2026070204403664000_16.7.e119507.9","doi-asserted-by":"publisher","DOI":"10.5230\/jgc.2023.23.e11"},{"key":"2026070204403664000_16.7.e119507.10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1053\/j.gastro.2024.11.025","article-title":"Effect of an Endoscopy Screening on Upper Gastrointestinal Cancer Mortality: A Community-Based Multicenter Cluster Randomized Clinical Trial","volume":"168","author":"Xia","year":"2025","journal-title":"Gastroenterology"},{"key":"2026070204403664000_16.7.e119507.11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333227"},{"key":"2026070204403664000_16.7.e119507.12","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-19104-6","article-title":"Global incidence and mortality trends of gastric cancer and predicted mortality of gastric cancer by 2035","volume":"24","author":"Lin","year":"2024","journal-title":"BMC Public Health"},{"key":"2026070204403664000_16.7.e119507.13","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21731"},{"key":"2026070204403664000_16.7.e119507.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.09.003"},{"key":"2026070204403664000_16.7.e119507.15","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1007\/BF02087683","article-title":"Bone disorders following total gastrectomy","volume":"39","author":"Wetscher","year":"1994","journal-title":"Digest Dis Sci"},{"key":"2026070204403664000_16.7.e119507.16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00595-024-02972-1","article-title":"Prognostic impact of osteosarcopenia on postoperative outcomes in patients with biliary tract cancer","volume":"55","author":"Shimagaki","year":"2025","journal-title":"Surg Today"},{"key":"2026070204403664000_16.7.e119507.17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.5114\/aoms.2015.55012","article-title":"Evaluation of the quality of life of postmenopausal osteoporotic and osteopenic women with or without fractures","volume":"12","author":"B\u0105czyk","year":"2016","journal-title":"Arch Med Sci"},{"key":"2026070204403664000_16.7.e119507.18","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6874-14-92","article-title":"Postmenopausal women with osteopenia and a healed wrist fracture have reduced physical function and quality of life compared to a matched, healthy control group with no fracture","volume":"14","author":"Hakestad","year":"2014","journal-title":"BMC Womens Health"},{"key":"2026070204403664000_16.7.e119507.19","doi-asserted-by":"crossref","first-page":"1403822","DOI":"10.3389\/fonc.2024.1403822","article-title":"Impact of osteopenia and osteosarcopenia on the outcomes after surgery of hepatobiliary-pancreatic cancers","volume":"14","author":"Wang","year":"2024","journal-title":"Front Oncol"},{"key":"2026070204403664000_16.7.e119507.20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10388-024-01101-8","article-title":"Prognostic impact of preoperative osteosarcopenia on esophageal cancer surgery outcomes: a retrospective analysis","volume":"22","author":"Hirase","year":"2025","journal-title":"Esophagus"},{"key":"2026070204403664000_16.7.e119507.21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/qjmed\/hcac015","article-title":"Bone mineral density, osteopenia and osteoporosis among US adults with cancer","volume":"115","author":"Huang","year":"2022","journal-title":"QJM"},{"key":"2026070204403664000_16.7.e119507.22","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-10-1121"},{"key":"2026070204403664000_16.7.e119507.23","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1097\/SLA.0000000000006326","article-title":"Major Pancreatic Resection Increases Bone Mineral Density Loss, Osteoporosis, and Fractures","volume":"282","author":"Khalilieh","year":"2025","journal-title":"Ann Surg"},{"key":"2026070204403664000_16.7.e119507.24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jjco\/hyaf003","article-title":"Impact of osteosarcopenia on short- and long-term outcomes in patients with gastric cancer","volume":"55","author":"Kai","year":"2025","journal-title":"Jpn J Clin Oncol"},{"key":"2026070204403664000_16.7.e119507.25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0324719","article-title":"Clinical impact of low bone mineral density in patients with colorectal cancer liver metastasis undergoing hepatectomy","volume":"20","author":"Aoki","year":"2025","journal-title":"PLoS One"},{"key":"2026070204403664000_16.7.e119507.26","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1200\/JCO.2025.43.16_suppl.12046","article-title":"New-onset osteopenia\/osteoporosis among long-term survivors of breast cancer: Role of hormone therapies and metabolic risk factors","volume":"43","author":"Bostany","year":"2025","journal-title":"JCO"},{"key":"2026070204403664000_16.7.e119507.27","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad137"},{"key":"2026070204403664000_16.7.e119507.28","doi-asserted-by":"crossref","unstructured":"Zhang Y , Wang Y , Sun D , et al . 99Tc-MDP maintains bone mineral density for postmenopausal differentiated thyroid cancer patients with osteopenia under thyroid-stimulating hormone suppression. Front Endocrinol 2025;16. doi:10.3389\/fendo.2025.1657617","DOI":"10.3389\/fendo.2025.1657617"},{"key":"2026070204403664000_16.7.e119507.29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01696"},{"key":"2026070204403664000_16.7.e119507.30","doi-asserted-by":"crossref","first-page":"1527829","DOI":"10.3389\/fmed.2025.1527829","article-title":"Predictive value of osteopenia as prognostic marker for survival and recurrence in patients with gastrointestinal cancers: a systematic review and meta-analysis","volume":"12","author":"Zou","year":"2025","journal-title":"Front Med"},{"key":"2026070204403664000_16.7.e119507.31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17172878","article-title":"Management of Bone Health Considerations in Patients with Cancer","volume":"17","author":"Brennan","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026070204403664000_16.7.e119507.32","article-title":"Understanding and Managing Fracture Risk in Patients With Cancer: A Literature Review","volume":"17","author":"Kourtis","year":"2025","journal-title":"Cureus"},{"key":"2026070204403664000_16.7.e119507.33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100355","article-title":"Updated guidance on the management of cancer treatment-induced bone loss (CTIBL) in pre- and postmenopausal women with early-stage breast cancer","volume":"28","author":"Waqas","year":"2021","journal-title":"J Bone Oncol"},{"key":"2026070204403664000_16.7.e119507.34","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70302-X"},{"key":"2026070204403664000_16.7.e119507.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60908-4"},{"key":"2026070204403664000_16.7.e119507.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60995-3"},{"key":"2026070204403664000_16.7.e119507.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809003"},{"key":"2026070204403664000_16.7.e119507.38","unstructured":"National Comprehensive Cancer Network . NCCN clinical practice guidelines in oncology (nccn guidelines\u00ae): breast cancer version 4. 2025."},{"key":"2026070204403664000_16.7.e119507.39","unstructured":"NCCN clinical practice guidelines in oncology (NCCN guidelines\u00ae): prostate cancer version 2 2026. 2025.1\u2013240."},{"key":"2026070204403664000_16.7.e119507.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00242-2"},{"key":"2026070204403664000_16.7.e119507.41","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"2026070204403664000_16.7.e119507.42","unstructured":"Weltgesundheitsorganisation, editors . Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [on assessment of fracture risk and its application to screening for postmenopausal osteoporosis, Rome, 22 - 25 June 1992]. Geneva: World Health Organization, 1992."},{"key":"2026070204403664000_16.7.e119507.43","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"2026070204403664000_16.7.e119507.44","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000054"},{"key":"2026070204403664000_16.7.e119507.45","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07098-5"},{"key":"2026070204403664000_16.7.e119507.46","doi-asserted-by":"crossref","unstructured":"Schwarzer G , R\u00fccker G . Meta-analysis of proportions. In: Evangelou E , Veroniki AA , eds. Meta-res., vol. 2345. Springer US, 2022: 159\u201372. Available: https:\/\/doi.org\/10.1007\/978-1-0716-1566-9_10","DOI":"10.1007\/978-1-0716-1566-9_10"},{"key":"2026070204403664000_16.7.e119507.47","doi-asserted-by":"publisher","DOI":"10.1097\/ede.0000000000001232"},{"key":"2026070204403664000_16.7.e119507.48","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1002\/sim.4040","article-title":"Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data","volume":"29","author":"Stijnen","year":"2010","journal-title":"Statist Med"},{"key":"2026070204403664000_16.7.e119507.49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jrsm.1348","article-title":"Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions","volume":"10","author":"Schwarzer","year":"2019","journal-title":"Res Synth Methods"},{"key":"2026070204403664000_16.7.e119507.50","doi-asserted-by":"publisher","DOI":"10.3923\/ijb.2009.1.35"},{"key":"2026070204403664000_16.7.e119507.51","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-015-0031-0","article-title":"Meta-analysis of incidence rate data in the presence of zero events","volume":"15","author":"Spittal","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"2026070204403664000_16.7.e119507.52","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557"},{"key":"2026070204403664000_16.7.e119507.53","unstructured":"Wang N . How to conduct a meta-analysis of proportions in R: a comprehensive tutorial 2018. n.d. Available: https:\/\/doi.org\/10.13140\/RG.2.2.27199.00161\/1"},{"key":"2026070204403664000_16.7.e119507.54","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A Re-Evaluation of Random-Effects Meta-Analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"2026070204403664000_16.7.e119507.55","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jrsm.1678","article-title":"Avoiding common mistakes in meta-analysis: Understanding the distinct roles of Q, I-squared, tau-squared, and the prediction interval in reporting heterogeneity","volume":"15","author":"Borenstein","year":"2024","journal-title":"Res Synth Methods"},{"key":"2026070204403664000_16.7.e119507.56","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-021-01381-z","article-title":"Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence","volume":"21","author":"Barker","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"2026070204403664000_16.7.e119507.57","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jrsm.1547","article-title":"Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity","volume":"13","author":"Migliavaca","year":"2022","journal-title":"Res Synth Methods"},{"key":"2026070204403664000_16.7.e119507.58","doi-asserted-by":"crossref","unstructured":"CMAJ . Development of the instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses. Available: https:\/\/www.cmaj.ca\/content\/192\/32\/E901 [Accessed 28 Nov 2025].","DOI":"10.1503\/cmaj.200077"},{"key":"2026070204403664000_16.7.e119507.59","unstructured":"R Core Team . R: a language and environment for statistical computing. 2025."},{"key":"2026070204403664000_16.7.e119507.60","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v036.i11"},{"key":"2026070204403664000_16.7.e119507.61","unstructured":"Popay J , Roberts H , Sowden A , et al . Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC methods programme. Lancaster University; 2006. Available: https:\/\/doi.org\/10.13140\/2.1.1018.4643"},{"key":"2026070204403664000_16.7.e119507.62","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/XEB.0000000000000158","article-title":"Rendering the Doi plot properly in meta-analysis","volume":"16","author":"Doi","year":"2018","journal-title":"Int J Evid Based Healthc"},{"key":"2026070204403664000_16.7.e119507.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.03.003"},{"key":"2026070204403664000_16.7.e119507.64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis","volume":"16","author":"Furuya-Kanamori","year":"2018","journal-title":"Int J Evid Based Healthc"},{"key":"2026070204403664000_16.7.e119507.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.07.015"},{"key":"2026070204403664000_16.7.e119507.66","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h870","article-title":"Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients","volume":"350","author":"Iorio","year":"2015","journal-title":"BMJ"},{"key":"2026070204403664000_16.7.e119507.67","doi-asserted-by":"crossref","unstructured":"Borges Migliavaca C , Stein C , Colpani V , et al . How are systematic reviews of prevalence conducted? A methodological study. BMC Med Res Methodol 2020;20. doi:10.1186\/s12874-020-00975-3","DOI":"10.1186\/s12874-020-00975-3"},{"key":"2026070204403664000_16.7.e119507.68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-022-06631-4","article-title":"Fracture risk and assessment in adults with cancer","volume":"34","author":"Ye","year":"2023","journal-title":"Osteoporos Int"},{"key":"2026070204403664000_16.7.e119507.69","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1302\/2633-1462.46.BJO-2023-0042.R1","article-title":"Prevalence of primary malignant tumours, rates of pathological fracture, and mortality in the setting of metastatic bone disease","volume":"4","author":"Christ","year":"2023","journal-title":"Bone Jt Open"},{"key":"2026070204403664000_16.7.e119507.70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pharmthera.2015.11.008","article-title":"Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials","volume":"158","author":"Van Acker","year":"2016","journal-title":"Pharmacol Ther"},{"key":"2026070204403664000_16.7.e119507.71","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0493-y"},{"key":"2026070204403664000_16.7.e119507.72","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjae068"},{"key":"2026070204403664000_16.7.e119507.73","doi-asserted-by":"publisher","DOI":"10.4065\/80.3.343"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-119507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:45:38Z","timestamp":1782992738000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-119507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":73,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,2]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2026-119507"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-119507","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}